Syndax Pharmaceuticals, Inc. (SNDX)

NASDAQ: SNDX · Real-Time Price · USD

19.41

-0.82 (-4.05%)

At close: May 18, 2026, 4:00 PM EDT

19.56

+0.15 (0.77%)

Pre-market: May 19, 2026, 6:38 AM EDT

Syndax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	130.89	134.93	154.08	295.39	74.36	221.97
Short-Term Investments	230.35	278.76	428.83	282.19	410.04	224.87
Cash & Short-Term Investments	361.24	413.69	582.91	577.58	484.4	446.83
Cash Growth	-30.04%	-29.03%	0.92%	19.24%	8.41%	52.47%
Accounts Receivable	38.12	38	7.6	-	-	-
Other Receivables	20.77	30.15	3.64	-	3.47	-
Total Trade Receivables	58.89	68.15	11.24	-	3.47	-
Inventory	34.95	32.75	0.37	-	-	-
Other Current Assets	16.1	13.5	8.54	3.29	1.92	1.57
Total Current Assets	471.18	528.08	603.06	580.88	489.79	448.4
Net Property, Plant & Equipment	1.39	1.52	2.02	1.5	1.06	1.26
Long-Term Investments	-	-	119.52	29.83	5.47	-
Other Long-Term Assets	0.1	0.1	0.22	0.68	0.92	-
Total Assets	472.67	529.71	724.82	612.88	497.24	449.66
Accounts Payable	10.84	16.58	11.63	9.96	4.35	5.67
Accrued Expenses	74.84	103.06	60.1	39.86	24.28	14.47
Current Portion of Leases	0.49	0.47	0.48	1.05	0.44	0.36
Other Current Liabilities	-	-	31.35	7.23	-	0.19
Total Current Liabilities	86.17	120.12	103.55	58.1	29.07	20.68
Long-Term Debt	-	-	-	-	-	19.9
Long-Term Leases	0.91	1.05	1.58	0.59	0.72	0.71
Other Long-Term Liabilities	343.97	343.91	331.57	-	-	-
Total Long-Term Liabilities	344.87	344.96	333.14	0.59	0.72	20.61
Total Liabilities	431.05	465.08	436.69	58.68	29.79	41.29
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,591	1,571	1,509	1,456	1,161	952.02
Accumulated Other Comprehensive Income	0.01	0.45	0.16	0.22	-0.81	0.05
Retained Earnings	-1,549	-1,507	-1,221	-902.4	-693.04	-543.7
Shareholders' Equity	41.62	64.63	288.12	554.2	467.45	408.37
Total Liabilities & Equity	472.67	529.71	724.82	612.88	497.24	449.66
Total Debt	1.4	1.52	2.06	1.64	1.16	20.97
Net Cash (Debt)	359.84	412.16	580.86	575.95	483.24	425.86
Net Cash Growth	-12.69%	-29.04%	0.85%	19.19%	13.47%	56.26%
Net Cash Per Share	4.13	4.76	6.78	8.19	7.95	7.94
Book Value	41.62	64.63	288.12	554.2	467.45	408.37
Book Value Per Share	0.48	0.75	3.37	7.88	7.69	7.62
Tangible Book Value	41.62	64.63	288.12	554.2	467.45	408.37
Tangible Book Value Per Share	0.48	0.75	3.37	7.88	7.69	7.62

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q